Edwards Lifesciences Corporation Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Amortized Cost
Edwards Lifesciences Corporation (EW) had Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Amortized Cost of $43.70 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Debt and Equity Securities › Available-for-Sale Securities, Debt Maturities
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost · last filed 2026-08-04
- 2026-06-30: Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Amortized Cost $43.70M.
- 2026-03-31: Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Amortized Cost $45.00M.
- 2025-12-31: Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Amortized Cost $46.10M.
- 2025-09-30: Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Amortized Cost $57.10M.
| Period end | Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Amortized Cost |
|---|---|
| 2026-06-30 | $43.70M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $45.00M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $46.10M 10-K · filed 2026-02-25 |
| 2025-09-30 | $57.10M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $65.50M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $75.00M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $88.10M 10-K · filed 2025-02-28 |
| 2024-09-30 | $98.40M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $123.60M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $163.30M 10-Q · filed 2024-04-29 |
| 2023-12-31 | $214.20M 10-K · filed 2024-02-12 |
| 2023-09-30 | $258.10M 10-Q · filed 2023-10-27 |
| 2023-06-30 | $306.10M 10-Q · filed 2023-07-28 |
| 2023-03-31 | $345.40M 10-Q · filed 2023-04-28 |
| 2022-12-31 | $427.30M 10-K · filed 2023-02-13 |
| 2022-09-30 | $491.40M 10-Q · filed 2022-10-28 |
| 2022-06-30 | $471.10M 10-Q · filed 2022-07-29 |
| 2022-03-31 | $503.60M 10-Q · filed 2022-04-28 |
| 2021-12-31 | $546.00M 10-K · filed 2022-02-14 |
| 2021-09-30 | $353.20M 10-Q · filed 2021-10-29 |
| 2021-06-30 | $253.70M 10-Q · filed 2021-07-30 |
| 2021-03-31 | $189.50M 10-Q · filed 2021-04-28 |
| 2020-12-31 | $177.70M 10-K · filed 2021-02-12 |
| 2020-09-30 | $147.90M 10-Q · filed 2020-10-26 |
| 2020-06-30 | $148.70M 10-Q · filed 2020-07-27 |
| 2020-03-31 | $159.10M 10-Q · filed 2020-04-28 |
| 2019-12-31 | $114.20M 10-K · filed 2020-02-14 |
| 2019-09-30 | $63.90M 10-Q · filed 2019-10-25 |
| 2019-06-30 | $63.20M 10-Q · filed 2019-07-26 |
| 2019-03-31 | $89.20M 10-Q · filed 2019-04-26 |
| 2018-12-31 | $102.50M 10-K · filed 2019-02-15 |
| 2018-09-30 | $87.60M 10-Q · filed 2018-10-26 |
| 2018-06-30 | $92.00M 10-Q · filed 2018-07-27 |
| 2018-03-31 | $106.10M 10-Q · filed 2018-04-27 |
| 2017-12-31 | $114.40M 10-K · filed 2018-02-16 |
| 2017-09-30 | $111.40M 10-Q · filed 2017-10-27 |
| 2017-06-30 | $104.40M 10-Q · filed 2017-07-28 |
| 2017-03-31 | $89.40M 10-Q · filed 2017-04-28 |
| 2016-12-31 | $85.90M 10-K · filed 2017-02-17 |
| 2016-09-30 | $79.80M 10-Q · filed 2016-10-28 |
| 2016-06-30 | $61.30M 10-Q · filed 2016-07-29 |
| 2016-03-31 | $53.50M 10-Q · filed 2016-04-29 |
| 2015-12-31 | $59.70M 10-K · filed 2016-02-19 |
| 2015-09-30 | $65.20M 10-Q · filed 2015-10-29 |
| 2015-06-30 | $63.50M 10-Q · filed 2015-07-29 |
| 2015-03-31 | $52.90M 10-Q · filed 2015-04-29 |
| 2014-12-31 | $42.90M 10-K · filed 2015-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |